DOSAGE & ADMINISTRATION SECTION
Apply once daily to clean face and neck, avoiding the eye area
MOOYAM PEELING SOLUTIONS
- Manufacturer
- Guangdong Miaolian Cosmetics Co., Ltd.
- Effective date
- 2024-12-24
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:48:41
Label at a glance#
ProductMOOYAM PEELING SOLUTIONS
Active ingredientSALICYLIC ACID
Label structure8 sections
Label contents#
Full prescribing information#
WARNINGS SECTION
Risk InformationFor external use only
Mention de risquesPour usage externe seulement
Do not use on damaged or broken skin.
Ne pas utiliser sur la peau endommagée ou avec des lésions
If rash occurs, discontinue use and consult a health care practitioner.
En présence d'une éruption cutanée, cesser l'utilisation et consulter un praticien de soins de santé
When using this product keep out of eyes. Rinse with water to remove.
Eviter tout contact avec les yeux. Rincer a l'eau le cas échéant
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
INACTIVE INGREDIENT SECTION
AQUA
PROPYLENE GLYCOL
PEG-400
PEG-40 HYDROGENATED CASTOR OIL
PEG-10
FRAGRANCE
CI 19140
SODIUM CHLORIDE
CI 15985
BUTYLENE GLYCOL
CENTELLA ASIATICA EXTRACT
POLYGONUM CUSPIDATUM ROOT EXTRACT
SCUTELLARIA BAICALENSIS ROOT EXTRACT
CAMELLIA SINENSIS LEAF EXTRACT
GLYCYRRHIZA GLABRA (LICORICE) ROOT EXTRACT
CHAMOMILLA RECUTITA (MATRICARIA) FLOWER EXTRACT
ROSMARINUS OFFICINALIS (ROSEMARY) LEAF EXTRACT
INDICATIONS & USAGE SECTION
1. Removes Dead Skin Cells
Exfoliating peeling oil helps dissolve and peel away dead skin cells on the surface of the skin, promoting cell turnover and leaving the skin smoother and more radiant.
2. Enhances Absorption
After exfoliation, the skin’s surface is free from obstructions, allowing it to better absorb active ingredients from subsequent skincare products such as serums and moisturizers, boosting their effectiveness.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
OTC - PURPOSE SECTION
1. Removes Dead Skin Cells
Exfoliating peeling oil helps dissolve and peel away dead skin cells on the surface of the skin, promoting cell turnover and leaving the skin smoother and more radiant.
2. Enhances Absorption
After exfoliation, the skin’s surface is free from obstructions, allowing it to better absorb active ingredients from subsequent skincare products such as serums and moisturizers, boosting their effectiveness.
OTC - ACTIVE INGREDIENT SECTION
SALICYLIC ACID ------1.9%
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| dea2eded-d1e7-46bb-9a3d-f8dc20de6277 | Product name | 1 | 20190408 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84507-026-01 | MOOYAM PEELING SOLUTIONS | 110 mL in 1 BOTTLE | OIL | 110 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- MOOYAM PEELING SOLUTIONS
- peeling oil
- SCUTELLARIA BAICALENSIS ROOT
- AQUA
- PROPYLENE GLYCOL
- PEG-40 HYDROGENATED CASTOR OIL
- PEG-10
- MATRICARIA RECUTITA
- PEG-400
- FRAGRANCE FLORAL ORC0902236
- SODIUM CHLORIDE
- ROSMARINUS OFFICINALIS (ROSEMARY) LEAF OIL
- CENTELLA ASIATICA
- POLYGONUM CUSPIDATUM ROOT
- GLYCYRRHIZA GLABRA (LICORICE) RHIZOME/ROOT
- CI 19140
- SALICYLIC ACID
- CI 15985
- BUTYLENE GLYCOL
- CAMELLIA SINENSIS LEAF
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84507-026 | 84507-026-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2a10d789-b2ee-48ab-e063-6394a90a9703 | 2a10d789-b2ed-48ab-e063-6394a90a9703 | 2024-12-24 | Warnings | 2a10d789-b2ee-48ab-e063-6394a90a9703 2a10d789-b2ed-48ab-e063-6394a90a9703 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.